Kamen AA - Search Results

1

Rapid High-Yield Production of Functional SARS-CoV-2 Receptor Binding Domain by Viral and Non-Viral Transient Expression for Pre-Clinical Evaluation.

Farnós O, Venereo-Sánchez A, Xu X, Chan C, Dash S, Chaabane H, Sauvageau J, Brahimi F, Saragovi U, Leclerc D, Kamen AA. Farnós O, et al. Among authors: kamen aa. Vaccines (Basel). 2020 Nov 4;8(4):654. doi: 10.3390/vaccines8040654. Vaccines (Basel). 2020. PMID: 33158147 Free PMC article.

2

Rational plasmid design and bioprocess optimization to enhance recombinant adeno-associated virus (AAV) productivity in mammalian cells.

Emmerling VV, Pegel A, Milian EG, Venereo-Sanchez A, Kunz M, Wegele J, Kamen AA, Kochanek S, Hoerer M. Emmerling VV, et al. Among authors: kamen aa. Biotechnol J. 2016 Feb;11(2):290-7. doi: 10.1002/biot.201500176. Epub 2015 Sep 24. Biotechnol J. 2016. PMID: 26284700

3

Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.

Venereo-Sanchez A, Gilbert R, Simoneau M, Caron A, Chahal P, Chen W, Ansorge S, Li X, Henry O, Kamen A. Venereo-Sanchez A, et al. Vaccine. 2016 Jun 17;34(29):3371-80. doi: 10.1016/j.vaccine.2016.04.089. Epub 2016 May 5. Vaccine. 2016. PMID: 27155499

4

Accelerated mass production of influenza virus seed stocks in HEK-293 suspension cell cultures by reverse genetics.

Milián E, Julien T, Biaggio R, Venereo-Sanchez A, Montes J, Manceur AP, Ansorge S, Petiot E, Rosa-Calatrava M, Kamen A. Milián E, et al. Vaccine. 2017 Jun 8;35(26):3423-3430. doi: 10.1016/j.vaccine.2017.04.065. Epub 2017 May 8. Vaccine. 2017. PMID: 28495315 Free article.

5

Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line.

Venereo-Sanchez A, Simoneau M, Lanthier S, Chahal P, Bourget L, Ansorge S, Gilbert R, Henry O, Kamen A. Venereo-Sanchez A, et al. Vaccine. 2017 Jul 24;35(33):4220-4228. doi: 10.1016/j.vaccine.2017.06.024. Epub 2017 Jun 22. Vaccine. 2017. PMID: 28648546

6

Characterization of influenza H1N1 Gag virus-like particles and extracellular vesicles co-produced in HEK-293SF.

Venereo-Sánchez A, Fulton K, Koczka K, Twine S, Chahal P, Ansorge S, Gilbert R, Henry O, Kamen A. Venereo-Sánchez A, et al. Vaccine. 2019 Nov 8;37(47):7100-7107. doi: 10.1016/j.vaccine.2019.07.057. Epub 2019 Jul 26. Vaccine. 2019. PMID: 31358407 Free article.

7

Establishing a Robust Manufacturing Platform for Recombinant Veterinary Vaccines: An Adenovirus-Vector Vaccine to Control Newcastle Disease Virus Infections of Poultry in Sub-Saharan Africa.

Farnós O, Gelaye E, Trabelsi K, Bernier A, Subramani K, Kallel H, Yami M, Kamen AA. Farnós O, et al. Among authors: kamen aa. Vaccines (Basel). 2020 Jun 26;8(2):338. doi: 10.3390/vaccines8020338. Vaccines (Basel). 2020. PMID: 32604755 Free PMC article.

8

Advancements in molecular design and bioprocessing of recombinant adeno-associated virus gene delivery vectors using the insect-cell baculovirus expression platform.

Joshi PRH, Venereo-Sanchez A, Chahal PS, Kamen AA. Joshi PRH, et al. Among authors: kamen aa. Biotechnol J. 2021 Apr;16(4):e2000021. doi: 10.1002/biot.202000021. Epub 2021 Jan 25. Biotechnol J. 2021. PMID: 33277815 Review.

9

Cross-validation of ELISA and a portable surface plasmon resonance instrument for IgG antibody serology with SARS-CoV-2 positive individuals.

Djaileb A, Hojjat Jodaylami M, Coutu J, Ricard P, Lamarre M, Rochet L, Cellier-Goetghebeur S, Macaulay D, Charron B, Lavallée É, Thibault V, Stevenson K, Forest S, Live LS, Abonnenc N, Guedon A, Quessy P, Lemay JF, Farnós O, Kamen A, Stuible M, Gervais C, Durocher Y, Cholette F, Mesa C, Kim J, Cayer MP, de Grandmont MJ, Brouard D, Trottier S, Boudreau D, Pelletier JN, Masson JF. Djaileb A, et al. Analyst. 2021 Jul 26;146(15):4905-4917. doi: 10.1039/d1an00893e. Analyst. 2021. PMID: 34250530

10

Vectored-Vaccine Platforms Enabled Rapid Development of Safe and Effective Vaccines in Response to COVID-19 Pandemic Situation.

Kamen AA. Kamen AA. Vaccines (Basel). 2021 Jul 2;9(7):722. doi: 10.3390/vaccines9070722. Vaccines (Basel). 2021. PMID: 34358139 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page